PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver disease |
| Phenotype | C0345905|intrahepatic cholangiocarcinoma |
| Sentences | 2 |
| PubMedID- 26070500 | Methods: topics discussed included the role of gadoxetic acid-enhanced mri in the differentiation of focal nodular hyperplasia from hepatocellular adenoma and small hepatocellular carcinoma (hcc) from small intrahepatic cholangiocarcinoma (in patients with chronic liver disease), the differentiation of low-grade dysplastic nodule (dn) from pre-malignant high-grade dn and early hcc, and treatment planning and assessment of treatment response for patients with hcc and colorectal liver metastasis. |
| PubMedID- 24186137 | Overall mutation rate of intrahepatic cholangiocarcinomas with chronic advanced liver disease (15/38, 39.5%, 95% confidence interval: 23.9-55.0) was lower than that of intrahepatic cholangiocarcinomas with normal liver (23/43, 53.5%, 95% confidence interval: 38.5-68.3). |
Page: 1